Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge

M Kontakou, R T Przemioslo, R P Sturgess, G A Limb, H J Ellis, P Day, P J Ciclitira, M Kontakou, R T Przemioslo, R P Sturgess, G A Limb, H J Ellis, P Day, P J Ciclitira

Abstract

This study investigated the presence of mRNA coding for interferon gamma (IFN gamma), tumour necrosis factor alpha (TNF alpha), and interleukins 2 (IL2) and 6 (IL6), in the mucosa of four coeliac patients in remission who had been challenged with either gliadin or synthetic gliadin oligopeptides. Jejunal biopsy specimens from these patients, taken before and at two, four, and six hours after challenge, were hybridised with specific 35S-labelled DNA oligonucleotide probes. The lamina propria of all the patients contained significantly increased numbers of cytokine mRNA expressing cells four hours after challenge with gliadin or an oligopeptide corresponding to amino acids 31-49 of A-gliadin (peptide A). No significant changes were seen with the peptides corresponding to aminoacids 202-220 (peptide B) or 3-21 (peptide C) of A-gliadin, with the exception of one patient who showed a significant increase in the number of TNF alpha mRNA expressing cells four hours after challenge with peptide B. In vivo studies in coeliac disease have shown that significant histological changes occur in the mucosa of treated coeliac patients four hours after challenge with either gliadin or peptide A. These findings suggest that the histological changes seen previously in the mucosa of coeliac patients after wheat peptide challenge may be caused by increased expression of cytokines within the mucosa.

References

    1. Gastroenterology. 1988 Jan;94(1):41-9
    1. Lancet. 1959 Sep 5;2(7097):252-5
    1. Scand J Immunol. 1988 Sep;28(3):351-7
    1. Gut. 1989 Mar;30(3):339-46
    1. Gastroenterology. 1989 Dec;97(6):1562-84
    1. Clin Exp Immunol. 1990 Aug;81(2):301-5
    1. J Immunol. 1990 Sep 15;145(6):1727-33
    1. Biochem J. 1990 Sep 1;270(2):313-8
    1. Clin Exp Immunol. 1991 Jan;83(1):79-84
    1. Hum Immunol. 1990 Nov;29(3):157-65
    1. J Clin Invest. 1991 May;87(5):1541-6
    1. Scand J Gastroenterol. 1991 Apr;26(4):392-8
    1. Gut. 1992 Nov;33(11):1482-6
    1. Immunology. 1993 Jan;78(1):127-31
    1. Gut. 1993 May;34(5):616-20
    1. Clin Exp Immunol. 1993 Oct;94(1):174-81
    1. Scand J Immunol. 1993 Dec;38(6):581-90
    1. Gut. 1993 Dec;34(12):1705-9
    1. J Clin Pathol. 1993 Dec;46(12):1097-100
    1. Lancet. 1994 Mar 26;343(8900):758-61
    1. Hum Immunol. 1994 Apr;39(4):243-52
    1. Gut. 1994 Aug;35(8):1037-41
    1. J Immunol. 1988 Oct 1;141(7):2325-9

Source: PubMed

3
Tilaa